Terveet vapaaehtoiset tutkittavat research hub

KF2025#1 trial: Ketamine, cannabidiol and cobicistat interaction study

This early-stage clinical trial is for healthy adult volunteers. Researchers are studying how three substances—ketamine, cannabidiol (CBD), and cobicistat—interact when taken together. The aim is to see how the body absorbs and breaks down these medicines, helping doctors understand if they can be safely combined in the future.